Group 1 - The biopharma industry is undergoing significant transformation, driven by the adoption of AI, cloud-native scientific computation, a shift away from animal testing, and increased reliance on model-informed drug development [3] - Simulations Plus is positioning itself to meet the industry's inflection point by enhancing its technology, services, and operating model, thereby strengthening its leadership and building an integrated ecosystem for future innovation [3] Group 2 - The agenda for the Investor Day includes an overview of the company's vision, mission, and values, highlights of company growth, major business components, industry environment, challenges and opportunities in drug development, software product strategy, fiscal year '26 roadmap, and a Q&A session [2] - The company is approaching its 30th anniversary, reflecting on its history of growth and the evolution of its business [2]